NCT05937230View on ClinicalTrials.gov

Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients

Active, not recruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

June 1, 2015

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2026

Conditions
Coronary Heart DiseaseAngioplasty, Balloon
Interventions
DEVICE

Drug-coated balloon

Paclitaxel is a pharmacologically active substance for anti-neointima.

DEVICE

Drug-eluting stents

Drug-eluting stent is composed of a metal stent, primer, and drug coating.

Trial Locations (1)

710032

Ling Tao, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT05937230 - Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients | Biotech Hunter | Biotech Hunter